Magnesium Sulfate • Perinatal Neuroprophylaxis

Slides:



Advertisements
Similar presentations
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Advertisements

Washington State Perinatal Collaborative Update on Quality Improvement Initiatives  Elective Deliveries 37-
Hypertension in Pregnancy
The ACOG Task force on hypertension in pregnancy
بسم الله الرحمن الرحيم.
1. Is MgSO 4 a Neuroprotector in Preterm delivery? 2.
HYPERTENSIVE DISEASE IN PREGNANCY WITH ASSOCIATED NEONATAL OUTCOMES
Cerebral Palsy “ What the Obstetrician Should Know” Donna Dizon-Townson, MD, FACOG Associate Professor Department of Obstetrics & Gynecology Division of.
Pretem Labor Ramzy Nakad, MD.
Choice of Anticonvulsant for Prevention and Management of Eclamptic Seizures F emi Oladapo Maternal and Fetal Health Research Unit, Department of Obstetrics.
The Limits of Viability: How Small Is Too Small?
Induction of Labor  Is the careful initiation of uterine contractions before their spontaneous onset.  Is the use of physical or chemical stimulants.
Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.
MANAGEMENT OF THE OBESE PREGNANT PATIENT Max Brinsmead PhD FRANZCOG May 2010.
Magnesium sulphate in the Management of Eclampsia in Malawi Dr. Chisale Mhango FRCOG 1 NPC Training in MNH.
Barbara V. Parilla, MD Clinical Professor of Obstetrics and Gynecology University of Illinois at Chicago Director, Maternal Fetal Medicine Advocate Lutheran.
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure Advances in Maternal and Neonatal Health.
Factors associated with perinatal deaths in women delivering in a health facility in Malawi Lily C. Kumbani, Johanne Sundby and Jon Øyvind Odland.
 Definition  Epidemiology  Risk factors  Screening  Diagnosis  Prevention  Management.
Christopher R. Graber, MD Salina Women’s Clinic September 27, 2011 (revised from Mar 2010)
Hypertension in Pregnancy
Hypertension in Pregnancy Updates: ACOG Task Force 2013.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
05_XXX_MM1 MATERNAL AND PERINATAL RESEARCH José Villar, Mariana Widmer, Mario Merialdi, Archana Shah for the WHO Maternal and Perinatal Research Network.
Definition: EPH-Gestosis is a disease of disturbed gestation, i.e. a high risk pregnancy. If this disturbance is demonstrated by abnormal body water retention.
Preterm Delivery: An Update on Prevention and Treatment Tara Lehman, MD MPH CCRMC June 3, 2009.
Author: Nagy Iulia Andrea Coordinator: Simon Márta, PhD, Lecturer Coauthor: Ortopan Maria, Oana Andrea Edina.
PRINCIPAL INVESTIGATOR: DR. GWAKO G. N SUPERVISORS: PROF. QURESHI Z.N; DR. KUDOYI W.O; PROF. WERE F. KNH/UON MNCH SYMPOSIUM UON LT3 10-Jan-2013.
Preterm labor.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
Christopher R. Graber, MD Salina Women’s Clinic Mar 3, 2010.
Preterm Labor 早 产 林建华. epidemiology Labor and delivery between 28 – weeks Labor and delivery between 28 – weeks 5%-10% 5%-10% be the leading.
Infection and white matter damage
Preterm Labor & Preterm Birth Family Medicine Specialist CME Vientiane, Lao PDR December 10 – 12, 2008.
MANAGEMENT OF PRETERM LABOR WITH INTACT MEMBRANES by Dr. Elmizadeh.
Aspirin for Pre- eclampsia? Max Brinsmead MB BS PhD July 2015.
Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader.
ANTENATAL CARE OF DIABETES IN PREGNANCY: AUDIT Rachael Read ST2 O&G Supervisor: Mr E Njiforfut Consultant.
The evidence for going to scale with Calcium supplementation Harshad Sanghvi Vice-President & Medical Director, Jhpiego Senior Advisor, Accelovate/USAID,
Causes of neonatal mortality Lawn JE, et al. Intl J Epidemiol (2006)
Precepting the Prenatal Patient: A Curriculum for Non OB Family Medicine Physicians.
MAGNESIUM SULPHATE IN OBSTETRICS MS CHARLEEN LIA SENIOR REGISTRAR IN OBSTETRICS AND GYNAECOLOGY.
Breech presentation.
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Barbara Schmidt, Kristine Sandberg Knisely Chair in Neonatology
Expectant management In pprom.
Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis Fetal Diagn Ther 2012;31:141–146.
Vignette and Discussion Questions
Chronic Hypertension Monitoring
Hypoxic Ischemic Encephalopathy Current trends in management
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Preeclampsia: an overview
Tabassum Firoz MD MSc FRCPC University of British Columbia
Evidence based management of preterm labour
Dr. Madhavi Karki.
THE UNIVERSITY of TENNESSEE HEALTH SCIENCE CENTER
Alexander Ansah Manu (BSc MD MSc PhD DLSHTM)
WHO recommendations on interventions to improve preterm birth outcomes
Operationalizing Inclusion
obesITY IN pregnanCY FOR UNDERGRADUATES
Figure cases 24 cases: neonatal or infant death
Hypertensive Disorders of Pregnancy
Chronic Hypertension If controlled hypertension, not recommended to deliver before 38 weeks Changes if uncontrolled and especially if growth restriction.
National Neonatal Audit Programme 2016
Alexander Ansah Manu (BSc MD MSc PhD DLSHTM)
Which NOAC and When for Stroke Prevention in AF?
The Ethics of Data Sharing in the Antenatal Corticosteroids Trial
Magnesium Sulphate in Obstetrics
Preeclampsia (continued)
Newborn Services, Women’s Health & Child Development Unit
Presentation transcript:

Magnesium Sulfate • Perinatal Neuroprophylaxis Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate • Perinatal Neuroprophylaxis Thomas R. Easterling, MD Professor Maternal-Fetal Medicine University of Washington Seattle, WA

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018 Long Term Survival

Impaired Work Capacity Preeclampsia Update 2006 11/13/2018 Cerebral Palsy Term Rate Impaired Work Capacity Term Rate

Preeclampsia Update 2006 11/13/2018 Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet, 1995;345

Antenatal Steroids Reduce the Incidence Of Cerebral Palsy Preeclampsia Update 2006 11/13/2018 Cerebral Palsy All trials 6.4% vs. 10.2% OR 0.59 (0.35-0.97) Antenatal Steroids Reduce the Incidence Of Cerebral Palsy

• < 30 weeks’ Gestation • MgSO4 - 4 g Bolus - 1 g per Hour Preeclampsia Update 2006 11/13/2018 • < 30 weeks’ Gestation • MgSO4 - 4 g Bolus - 1 g per Hour • 2 Year Follow-up

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018

• < 24-31 weeks’ Gestation • MgSO4 - 4 g Bolus - 2 g per Hour Preeclampsia Update 2006 11/13/2018 • < 24-31 weeks’ Gestation • MgSO4 - 4 g Bolus - 2 g per Hour • 2 Year Follow-up

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018

• < 33 weeks’ Gestation • MgSO4 - 4 g Bolus - no maintenance Preeclampsia Update 2006 11/13/2018 • < 33 weeks’ Gestation • MgSO4 - 4 g Bolus - no maintenance • At Hospital Discharge

WMI - white matter injury Preeclampsia Update 2006 11/13/2018 WMI - white matter injury

• 5 Clinical Trial with 6145 Babies • Cerebral Palsy (RR) 0.68 CI (0.54 to 0.87) • Gross Motor Dysfunction (RR) 0.61 CI (0.44 to 0.85) “The neuroprotective role for antenatal magnesium sulfate … is now established.” The number of women to treat to benefit one baby is 63; 95% CI (43 to 155).

Cerebral Palsy

Gross Motor Dysfunction

Pediatric Mortality

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018

Preeclampsia Update 2006 11/13/2018 1 1 2 2 3 3

Preeclampsia Update 2006 11/13/2018

Mg++ Neuroprophylaxis Mechanism NMDA - (N-methyl-D-aspartate) Preeclampsia Update 2006 11/13/2018 Mg++ Neuroprophylaxis Mechanism CNS NMDA - (N-methyl-D-aspartate) Hypoxia • activation of NMDA and non-NMDA receptors by the excitatory neurotransmitter, glutamine • increased intracellular Ca++ • intracellular Ca++ - free radical generation and cell death

Preeclampsia Update 2006 11/13/2018

Mg++ Neuroprophylaxis Mechanism Microvascular Stabilization Preeclampsia Update 2006 11/13/2018 Mg++ Neuroprophylaxis Mechanism non-CNS Microvascular Stabilization Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial Lancet, 1995;345

Magnesium Sulfate for Neuroprotection Final Recommendations - draft Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate for Neuroprotection Final Recommendations - draft • Indication Imminent preterm delivery Not limited by cause of risk (eg. PROM, PTL, preeclampsia, bleeding…) • Gestational Age < 28 weeks gestation – recommended 28-34 weeks gestation - offered with counseling • Dose 4 gm bolus, followed by 1gm/hour infusion. Mg levels not indicated without renal complications. • Discontinuation undelivered in 12 hours • Restart recurrent risk for preterm delivery >3 hours from d/c - rebolus • Urgent delivery should not be delayed to wait for MgSO4

Impaired Work Capacity Preeclampsia Update 2006 11/13/2018 Cerebral Palsy Term Rate Impaired Work Capacity Term Rate

Magnesium Sulfate for Neuroprotection Final Recommendations - draft Preeclampsia Update 2006 11/13/2018 Magnesium Sulfate for Neuroprotection Final Recommendations - draft • Indication Imminent preterm delivery Not limited by cause of risk (eg. PROM, PTL, preeclampsia, bleeding…) • Gestational Age < 28 weeks gestation – recommended 28-34 weeks gestation - offered with counseling • Dose 4 gm bolus, followed by 1gm/hour infusion. Mg levels not indicated without renal complications. • Discontinuation undelivered in 12 hours • Restart recurrent risk for preterm delivery >3 hours from d/c - rebolus • Urgent delivery should not be delayed to wait for MgSO4